CEO Strategic Leadership Series

CEO Strategic Leadership Series

Healthcare & Life Sciences

The healthcare and life sciences sector is under immense strain as demographic pressures, workforce shortages, cost escalation, and scientific breakthroughs converge. At the same time, digital health, precision medicine, AI-driven diagnostics, and decentralized trials are transforming patient care and innovation pipelines. CEOs must navigate regulatory uncertainty, integration complexity, and rising expectations for access, equity, and transparency. This series examines the forces disrupting clinical operations, R&D, supply chains, and payer models — and identifies where strategic investment will produce the greatest returns. Arcus supports leaders in building future-ready organizations capable of delivering high-quality care and scientific advancement at scale.

The North American Health System Is Entering a Workforce Collapse — And No Amount of Recruitment Will Fix It

AI in Healthcare Is Moving Faster Than Regulation — And CEOs Must Prepare for a Governance Shock

The Patient Experience Crisis Is a Strategic Risk — Not a Satisfaction Issue

Primary Care Is Collapsing — And Health Systems Must Prepare for a Post-PCP Care Model

Hospitals Are Becoming Data Factories — But Their Data Infrastructure Is Now the Biggest Barrier to Innovation

Virtual Care Is Stalling — Because Health Systems Built It on the Wrong Economic Model

Life Sciences Supply Chains Are Becoming Geopolitical Battlegrounds — And Biopharma Executives Must Rethink Global Footprints

Hospitals Are Hitting an Inflection Point: Capital Spending Must Shift from Buildings to Systems

The Clinical Trials Model Is Breaking — And North America Needs a New Blueprint for Patient Recruitment and Diversity

Pharma Commercial Models Are Failing Because They Ignore How Clinicians Actually Make Decisions

Healthcare Cybersecurity Is Entering a Catastrophic Phase — And Most Hospitals Are Defenceless

Why Diagnostic Backlogs Are Getting Worse — Even as Health Systems Expand Capacity

Precision Medicine Is Outpacing Clinical Operations — And Hospitals Are Not Ready for Genomic Workflows

Health Insurance Is Entering a New Instability Cycle — Cost Trends Are Breaking Every Forecast Model

Public Health Is Fragmenting — And North America Is Not Prepared for the Next Multi-System Outbreak

Biotech Investment Is Entering a Darwinian Phase — Only Platforms, Not Products, Will Survive

Hospitals Are Drowning in Low-Value Care — And Cutting It Could Unlock 15–25% Capacity

Mental Health Demand Is Surging — But the Delivery Model Is Not Built for Scale

MedTech Is Stalling Because Commercial Models Haven’t Kept Up With Value-Based Care

The Future of Healthcare Will Be Built Around Predictive Operations — Not Reactive Care